Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Testis-expressed protein 55 (TEX55) is a protein encoded by the C3orf30 gene located on chromosome 3 (3q13.32) in humans[1][3][7]. The protein is predominantly produced in the testis and is believed to act as an anchoring protein for cAMP-dependent type II protein kinase (putative A-kinase anchoring protein/AKAP)[1][2]. It is highly conserved among mammals and its expression correlates with spermatogenic activity. Reduced TEX55 expression is observed in certain forms of male infertility such as cryptorchidism, Sertoli-cell-only syndrome, and teratozoospermia[1][2]. Despite its testis-specific expression and putative involvement in spermatogenesis, gene knockout studies in mice indicate that TEX55 is dispensable for male fertility, possibly due to functional redundancy with other proteins[2]. TEX55 is not associated with any approved drugs or recognized as a clinical therapeutic target[3][6][7]. Its most significant clinical relevance lies in its potential utility as a biomarker for assessing testicular function and male infertility[1][2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Testis-expressed protein 55 (TEX55).